VRNA

Verona Pharma
VRNA

Delisted

VRNA was delisted on the 6th of October, 2025.

37 hedge funds and large institutions have $234M invested in Verona Pharma in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
5
Reduced
6
Closed
6
Calls
$4K
Puts
$35K
Net Calls
-$31K
Net Calls Change
+$69K
Name Holding Trade Value Shares
Change
Shares
Change %
O
1
OrbiMed
New York
$37.2M
NMC
2
NEA Management Company
Maryland
$33.4M
RCM
3
RA Capital Management
Massachusetts
$33.4M
Wellington Management Group
4
Wellington Management Group
Massachusetts
$25.6M +$744K +113,699 +3%
VC
5
Vivo Capital
California
$19.9M
PA
6
Perceptive Advisors
New York
$18.9M
A
7
Abingworth
United Kingdom
$16M
ACM
8
Aisling Capital Management
New York
$8.71M
FCMI
9
Foresite Capital Management III
California
$7.27M
SB
10
Samsara BioCapital
California
$7.27M
GTC
11
Ghost Tree Capital
New York
$6.54M +$399K +60,957 +6%
SFM
12
Sphera Funds Management
Israel
$5.24M
NHAS
13
Novo Holdings A/S
Denmark
$4.98M -$505K -77,155 -9%
TCM
14
Tekla Capital Management
Massachusetts
$4.92M
BlackRock
15
BlackRock
New York
$1.64M +$1.64M +249,941 New
VP
16
venBio Partners
California
$1.06M
FFM
17
Fairmount Funds Management
Pennsylvania
$549K
SSA
18
Schonfeld Strategic Advisors
New York
$381K +$11.1K +1,700 +3%
DADC
19
D.A. Davidson & Co
Montana
$274K
IWM
20
IHT Wealth Management
Illinois
$121K -$848 -130 -0.7%
WS
21
Wedbush Securities
California
$118K -$25.9K -3,965 -18%
FA
22
Forefront Analytics
Pennsylvania
$104K +$9.42K +1,404 +10%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$101K
QSS
24
Quantitative Systematic Strategies
Florida
$92K -$99.2K -15,136 -52%
RG
25
Rathbones Group
United Kingdom
$78K